When discussing liver disease, alcohol comes up a lot. We know that everything we take in passes through the liver, and alcohol weighs heavily on the highly important organ.
But there is another culprit that is often overlooked in discussions regarding the liver, even though it is a large contributor to nonalcoholic fatty liver disease (NAFLD).
Nonalcoholic fatty liver disease is when fat accumulates in the liver, and it’s beginning to surpass alcoholic liver disease as a leading cause of liver failure.
As our waistlines continue to grow, the fat in our livers also increases; the item to blame for this crisis is none other than sugar.
Liver disease comprises of wide range of complex conditions affecting the liver. Liver disease treatment market is assured to grow on account of unmet clinical needs and upcoming treatment modifications. Number of novel agents has shown improvements in clinical trials such as obeticholic acid, thiazolidinediones and vitamin E for treatment of nonalcoholic fatty liver diseases. Additionally, according to American Cancer Society liver cancer rates increases 2.7% every year propelling the growth of market.